Literature DB >> 18343432

Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence.

Hong Gee Sim1, Donatello Telesca, Stephen H Culp, William J Ellis, Paul H Lange, Lawrence D True, Daniel W Lin.   

Abstract

PURPOSE: Gleason sum 7 prostate cancers are a heterogeneous group with diverse tumor behaviors and disease outcomes. Tertiary Gleason patterns are reported with increasing frequency, particularly in prostatectomy pathology reports. We studied the pathological and biochemical outcome following radical prostatectomy in men with Gleason sum 7 and tertiary Gleason pattern 5.
MATERIALS AND METHODS: We reviewed 1,110 cases of clinically localized prostate cancer treated with primary radical prostatectomy between January 1998 and August 2006 through a prospectively collected prostate cancer database. Patients who underwent neoadjuvant or adjuvant hormonal deprivation, radiation or systemic chemotherapy were excluded.
RESULTS: Of the 1,110 patients 509 had Gleason sum 7 cancer. Tertiary Gleason pattern was present in 66 of 509 cases (13%) and it was absent in 443 (87%). On multivariate analysis tertiary Gleason pattern 5 was associated with higher pT stage (OR 2.55, 95% CI 1.40-4.65) and biochemical recurrence (HR 1.78, 95% CI 1.00-3.17). On subgroup analysis when patients with Gleason sum 3 + 4 + 5 and 4 + 3 + 5 were compared to their respective referent groups without the tertiary Gleason pattern, the 2 groups showed a trend toward higher pathological stage and prostate specific antigen progression. Patients with Gleason sum 3 + 4 with no tertiary pattern had higher PSA recurrence-free probability than those with Gleason sum 3 + 4 + 5 or 4 + 3 and patients with Gleason sum 4 + 3 + 5 had the lowest PSA recurrence-free probability.
CONCLUSIONS: In patients with Gleason sum 7 prostate cancer tertiary Gleason grade 5 is significantly associated with higher pT stage and biochemical recurrence. Larger studies are needed to assess the predictive value of tertiary grade compared to other established parameters in predicting the long-term oncological outcome after radical prostatectomy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343432     DOI: 10.1016/j.juro.2008.01.016

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

1.  Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes?

Authors:  Hillary M Ross; Oleksandr N Kryvenko; Janet E Cowan; Jeffry P Simko; Thomas M Wheeler; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2012-09       Impact factor: 6.394

2.  Prostate cancer: Effects of tertiary Gleason pattern 5 on oncological outcome.

Authors:  Sean R Williamson; Liang Cheng
Journal:  Nat Rev Urol       Date:  2015-01-20       Impact factor: 14.432

3.  Biochemical outcome of small-volume or insignificant prostate cancer treated with radical prostatectomy in Japanese population.

Authors:  Yasuhiro Hashimoto; Akiko Okamoto; Atsushi Imai; Tohru Yoneyama; Shingo Hatakeyama; Takahiro Yoneyama; Takuya Koie; Noritaka Kaminura; Chikara Ohyama
Journal:  Int J Clin Oncol       Date:  2011-06-16       Impact factor: 3.402

Review 4.  Grading of Prostate Cancer: Past, Present, and Future.

Authors:  Andres Matoso; Jonathan I Epstein
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

5.  Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1,248 patients with Gleason 7 tumors.

Authors:  Olivier Alenda; Guillaume Ploussard; Pascal Mouracade; Evanguelos Xylinas; Alexandre de la Taille; Yves Allory; Dimitri Vordos; Andras Hoznek; Claude Clement Abbou; Laurent Salomon
Journal:  World J Urol       Date:  2010-11-24       Impact factor: 4.226

6.  Definition of biochemical recurrence after radical prostatectomy does not substantially impact prognostic factor estimates.

Authors:  Angel M Cronin; Guilherme Godoy; Andrew J Vickers
Journal:  J Urol       Date:  2010-01-18       Impact factor: 7.450

7.  Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort.

Authors:  Jonathan L Wright; Claudia A Salinas; Daniel W Lin; Suzanne Kolb; Joseph Koopmeiners; Ziding Feng; Janet L Stanford
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

8.  Impact of Gleason pattern 5 including tertiary pattern 5 on outcomes of salvage treatment for biochemical recurrence in pT2-3N0M0 prostate cancer.

Authors:  Satoru Taguchi; Kenshiro Shiraishi; Hiroshi Fukuhara; Keiichi Nakagawa; Teppei Morikawa; Akihiro Naito; Shigenori Kakutani; Yuta Takeshima; Hideyo Miyazaki; Tohru Nakagawa; Tetsuya Fujimura; Haruki Kume; Yukio Homma
Journal:  Int J Clin Oncol       Date:  2016-04-20       Impact factor: 3.402

9.  Tertiary Gleason patterns and biochemical recurrence after prostatectomy: proposal for a modified Gleason scoring system.

Authors:  Bruce J Trock; Charles C Guo; Mark L Gonzalgo; Ahmed Magheli; Stacy Loeb; Jonathan I Epstein
Journal:  J Urol       Date:  2009-08-14       Impact factor: 7.450

10.  Clinical significance of prospectively assigned Gleason tertiary pattern 4 in contemporary Gleason score 3+3=6 prostate cancer.

Authors:  Chirag Doshi; Michael Vacchio; Kristopher Attwood; Christine Murekeyisoni; Diana C Mehedint; Shervin Badkhshan; Gissou Azabdaftari; Norbert Sule; Khurshid A Guru; James L Mohler; Eric C Kauffman
Journal:  Prostate       Date:  2016-02-16       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.